NPCE
NeuroPaceCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
Current thesis
Accelerating implant volumes, broader reimbursement, and positive clinical readouts drive revenue growth and multiple expansion toward the analyst high (23.1).
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -9.9.
What can break
Commercial execution or manufacturing failures
Momentum
74
Value
36
Sentiment
54
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $18.80 · Bull $23.10 · Bear $15.00
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-17 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $19.88
Why
Momentum74 · Δ7d -9.9
Value36 · Δ7d -0.0
Sentiment54 · Δ7d +3.3
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
74
34% active weight
Current posture
7d trendFlat
Δ7d
-9.9
Δ21d
-15.5
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
54
33% active weight
Current posture
7d trendImproving
Δ7d
+3.3
Δ21d
+3.8
Why this grade
Composite grade C. Momentum 74.5 / Value 36.3 / Sentiment 54.2
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$555.39M
Beta
1.86
Shares Out
33.28M
P/E (TTM) · Derived
-17.9
P/S (TTM)
5.53
P/FCF (TTM) · Derived
-32.05
Rev YoY
+29.9%
EPS YoY
+43.0%
Gross Margin
+76.8%
Op Margin
-19.7%
Net Debt
$6.77M
Current Ratio
4.86
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology